BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

A four-biomarker blood panel of aminopeptidase N, polymeric immunoglobulin receptor, CA19-9, and thrombospondin-2 enhanced ...

Lucid's Q3 2025 showed 2,841 tests and $7.1 million in pro forma revenues billed, but only $1.2 million could be ...

Antibodies are the immune system's precision tools for recognizing and neutralizing viruses, bacteria and other foreign ...

Plastic pollution is everywhere—including where you would least expect it, especially when it's in tiny particle form. Today, ...

How the three-time Olympic medalist became freestyle skiing's biggest star ...

Discusses Technology and Digital Innovation Driving Growth in Animal Health January 23, 2026 4:00 PM ESTCompany ...

t (Duration of Full-Power Continuous Discharge): Refers to the total duration an energy storage station can discharge continuously at its rated power until its energy is depleted. It is determined by ...

Panels designed to identify acute cellular rejection, antibody-mediated rejection without ...